©2019 by Kristine Shields, Author. All Rights Reserved. Created on Wix by Webhil.com

  • Facebook - Black Circle
  • Twitter - Black Circle
  • LinkedIn - Black Circle

PUBLICATIONS/PRESENTATIONS

Kristine Shields MSN, DrPH

PUBLICATIONS

Click the button below to view my past publications

SELECTED PRESENTATIONS

Pending: Shields KE. Implementing New FDA Policy to Include Pregnant Women in Drug Trials to Achieve Evidence-based Pharmacotherapy. Poster presentation at the American Public Health Association Annual Meeting.

Philadelphia, PA

November 2-6, 2019

Pending: Shields KE. The Inclusion of Pregnant Women in Clinical Trials. Oral presentation at the Advancing Ethical Research Conference.

Boston, MA

November 18-20, 2019

Shields KE. Pregnancy Registries' Contribution to Informed Clinical Practice. Invited oral presentation at the Third Annual International Conference for Individualized Pharmacotherapy in Pregnancy.

Indianapolis, IN

June 7, 2010

Shields KE, The HPV Vaccine - Examining the Safety Profile of Gardasil. Invited oral presentation at the Nurse Practitioners in Women’s Health Post-Graduate Seminar.

Atlantic City, NJ

February 2009

Shields KE, New FDA Pregnancy Labeling - How it will inform your clinical practice. Invited oral presentation at the Nurse Practitioners in Women’s Health Post-Graduate Seminar.

Atlantic City, NJ

February 2009

Shields KE, Informed consent processes in pregnancy registries. Invited oral presentation at the 48th Annual Meeting of the Teratology Society.

Monterey, CA

July 2008

Abstract: Birth Defects Research (Part A), 82(5):336 (2008)

Shields KE. Sources of pregnancy exposure information – U.S. and worldwide. Invited oral presentation at the Teratology Society 45th Annual Meeting.

St. Pete’s Beach, FL

25-30 June 2005

Shields KE. Pregnancy registries as risk management tools. Invited oral presentation at PEA’s 4th Annual Risk Management Conference.

Philadelphia, PA

25-26 October 2005

Shields KE. A Pregnancy Registry Program in a Regulatory Environment. Invited oral presentation at the DIA symposium, Pregnancy Exposure Registries: Evaluating the Teratogenic Potential of Pharmaceutical Products Used at Clinical Doses.

Washington DC

May 24-25, 2004

Shields, KE. The Merck Pregnancy Registry Program. Invited oral presentation at Drug Information Association 11th Annual Symposium on Medical Communications.

Washington, DC

March 2000

Shields, KE. Pregnancy registries: Your role in drug safety assessment. Oral presentation at the Nurse Practitioners in Women’s Health Post-Graduate Seminar.

Philadelphia, PA

February 2000

Shields, KE; Galea, S; Sweet, A; & Seward, J.  Three-Year Results from the Pregnancy Registry for VARIVAX®. Poster presentation.

DIA Canada – Quebec

June 1999

Shields KE, Galil K, Sharrar RG, Seward, J, Wiholm BE. Industry/CDC collaboration: The Pregnancy Registry for VARIVAX. Poster presentation at the First CDC Conference on Birth Defects and Developmental Disabilities: Charting the Course.

Atlanta, GA

September 19, 2002

Shields KE, Bold T, Sharrar, RG. Pregnancy Registry for Singulair: Three-year analysis of data. Oral presentation at the World Asthma Meeting.

Chicago, IL

July 14, 2001